Abstract: The present invention relates to novel substituted benzfurochromenes and related compounds having the general formula (I), salts and chiral, achiral derivatives thereof; wherein R1, R2, R3, R4, R5, R6, R7, R8 are independently selected from the groups consisting of hydrogen, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkoxyl, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted alkylthio, optionally substituted amino, optionally substituted acylamino, optionally substituted arylamino, optionally substituted acylthio, optionally substituted acyl, optionally substituted aroyl, optionally substituted acyloxy, optionally substituted thioamido, halogens, nitriles, esters, hydroxy, mercapto, carbontrifluoride, nitro but not limited to this; wherein R1R2 or R2R3 or R6R7 may be connected and form either a five membered ring or a six membered ring such as optionally substituted furan, optionally substituted dihydrofuran, optionally substituted

Abstract: A process for the preparation of nano structured silicon thin film using radio frequency (rf) plasma discharge useful for light emitting devices such as light emitting diode, laser etc. which allows precise control of the nanocrystal size of silicon and its uniform distribution without doping using a plasma processing for obtaining efficient photoluminescence at room temperature.

Abstract: Provided is a remote mobile device access and control method, and particularly a generic approach for providing remote mobile device access and control. To this end, there is provided a method for a user to access and control his/her mobile device at a remote location by using a remote mobile device access and control architecture that allows the user to access an application and data of his/her mobile device.

Abstract: A computer-implemented method supporting collaborative product development. A plurality of artifacts associated with the collaborative product development is maintained under revision control in a first repository. Each artifact has a plurality of lifecycle states and each artifact is associated with a first finite state machine (FSM) that defines lifecycle state transitions for the artifacts. A plurality of artifact tuples associated with the collaborative product development is maintained under revision control in a second repository. At least one artifact tuple is comprised of at least one access information providing access to at least one of said plurality of artifacts in the first repository. Each artifact tuple has a plurality of lifecycle states and each artifact tuple is associated with a second finite state machine (FSM) that defines lifecycle state transitions for the artifact tuples.

Abstract: Compounds having the structure (or their salts): are used to treat or reduce the likelihood of acquiring androgen-dependent diseases, such as prostate cancer, benign prostatic hyperplasia, polycystic ovarian syndrome, acne, hirsutism, seborrhea, androgenic alopecia and male baldness. The compounds can be formulated together with pharmaceutically acceptable diluents or carriers or otherwise made into any pharmaceutical dosage form. Combinations with other active pharmaceutical agents are also disclosed.

Abstract: A plasma based deposition process to deposit thin film on the inner surfaces of the shaped objects such as plastic or metallic object like bottles, hollow tubes etc. at room temperature has been developed. In present invention uniform hydrogenated amorphous carbon (also called Diamond-Like Carbon, DLC) films on inner surfaces of plastic bottles is successfully deposited. Applications of such product include entire food and drug industries. There is a huge demand of polyethylene terephthalate (PET) or polyethylene naphthalate (PEN)) bottles, meant for the storage of potable water, carbonated soft drinks, wines, medicines etc. However, the higher cost prohibits their wide, spread use. The cheaper alternative is to use plastic bottles inside coated with chemically inert material such as Diamond-Like Carbon (DLC) will be commercially viable. Inventor process can be scaled up for mass production.

Abstract: This invention relates to a paper substrate containing high surface sizing and low internal sizing and having high dimensional stability, as well as methods of making and using the composition.

Abstract: The present invention relates to novel substituted benzfurochromenes and related compounds having the general formula (I), salts and chiral, achiral derivatives thereof; wherein R1, R2, R3, R4, R5, R6, R7, R8 are independently selected from the groups consisting of hydrogen, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkoxyl, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted alkylthio, optionally substituted amino, optionally substituted acylamino, optionally substituted arylamino, optionally substituted acylthio, optionally substituted acyl, optionally substituted aroyl, optionally substituted acyloxy, optionally substituted thioamido, halogens, nitriles, esters, hydroxy, mercapto, carbontrifluoride, nitro but not limited to this; wherein R1R2 or R2R3 or R6R7 may be connected and form either a five membered ring or a six membered ring such as optionally substituted furan, optionally substituted dihydrofuran, optionally substituted

Abstract: A catalyst for hydrotreating, especially hydrodesulfurization, of residua and heavy crudes is prepared by synthesizing the support from titanium and boehmite, to form either a titanium/alumina support (TiO2/Al2O3) or a titanium-alumina support (TiO2—Al2O3) that is thereafter provided with at least one hydrogenating metal from group VIB in oxide form and a promoter from group VIII also in oxide form. The (TiO2/Al2O3) support is prepared from boehmite, which is peptized by using an inorganic acid, then extruded, calcined and impregnated with a solution containing titanium, while the (TiO2—Al2O3) support is prepared by admixing boehmite with a titanium-containing solution, peptized using an inorganic acid, extruded and calcined to obtain the titanium-alumina support.

Abstract: A catalyst for hydrotreating, especially hydrodesulfurization, of residua and heavy crudes is prepared by synthesizing the support from titanium and boehmite, to form either a titanium/alumina support (TiO2/Al2O3) or a titanium-alumina support (TiO2—Al2O3) that is thereafter provided with at least one hydrogenating metal from group VIB in oxide form and a promoter from group VIII also in oxide form. The (TiO2/Al2O3) support is prepared from boehmite, which is peptized by using an inorganic acid, then extruded, calcined and impregnated with a solution containing titanium, while the (TiO2—Al2O3) support is prepared by admixing boehmite with a titanium-containing solution, peptized using an inorganic acid, extruded and calcined to obtain the titanium-alumina support.

Abstract: The invention relates to a method for synthesizing a hydroprocessing catalyst, wherein the support is prepared by mixing peptized aluminium with amorphous silica or with crystalline aluminium silicate as a catalyst component. The catalyst comprises a metal from group VIB and/or a metal from group VIIIB of the Periodic Table. The catalyst exhibits enhanced activity vis-à-vis hydrodisintegration, hydrodemetallization and hydrodesulphurization, and has a relatively stable life as a function of run time. Thus, the invention relates to a method for developing a catalyst for hydroprocessing heavy hydrocarbon feedstocks, which is characterized in that it comprises two steps: the first step involves optimization of the catalyst formulation with respect to textural properties, the number of acid sites and incorporation of the active metal; the second step involves evaluation with real feedstocks and the stability of the catalyst as is function of run time.

Abstract: An improved catalyst for hydrodemetallization of heavy crude oils and residua is disclosed. The catalyst is adopted for fixed bed hydroprocessing units. The invention is characterized for having a large pore diameter catalyst principally for hydrodemetallization of heavy oil and residue in a first reactor of a multi-reactor process. The catalyst has high demetallizing activity and high metal deposition capacity which results in good stability with time on stream (TOS). The hydrorefining catalyst is obtained by kneading a porous starting powder principally composed of gamma-alumina and having a pore capacity of 0.3-0.6 ml/g or larger and a mean pore diameter of 10 to 26 nm, extrudating and calcining, and after that supported with active metals component of elements belonging to groups VIIIB and VIB of the periodic table.

Abstract: The present invention provides a process for the preparation of nano structured silicon thin film using radio frequency (rf) plasma discharge useful for light emitting devices such as light emitting diode, laser etc. The present invention shows the possibility of precise control of the nanocrystal size of silicon and its uniform distribution without doping using plasma processing for obtaining efficient photoluminescence at room temperature. Process developed to deposit the photo luminescent nano structured silicon thin films using plasma enhanced chemical vapour deposition technique can find use in electroluminescence devices like light emitting diodes (LEDs), LASER etc. This could also be advantageous for integration of silicon photonic devices with the existing silicon microelectronic technology.

Abstract: This invention relates to a paper substrate containing high surface sizing and low internal sizing and having high dimensional stability, as well as methods of making and using the composition.

Abstract: Compounds having the structure (or their salts): are used to treat or reduce the likelihood of acquiring androgen-dependent diseases, such as prostate cancer, benign prostatic hyperplasia, polycystic ovarian syndrome, acne, hirsutism, seborrhea, androgenic alopecia and male baldness. The compounds can be formulated together with pharmaceutically acceptable diluents or carriers or otherwise made into any pharmaceutical dosage form. Combinations with other active pharmaceutical agents are also disclosed.

Abstract: This invention relates to a paper substrate containing high surface sizing and low internal sizing and having high dimensional stability, as well as methods of making and using the composition.

Abstract: Compounds having the structure (or their salts): are used to treat or reduce the likelihood of acquiring androgen-dependent diseases, such as prostate cancer, benign prostatic hyperplasia, polycystic ovarian syndrome, acne, hirsutism, seborrhea, androgenic alopecia and male baldness. The compounds can be formulated together with pharmaceutically acceptable diluents or carriers or otherwise made into any pharmaceutical dosage form. Combinations with other active pharmaceutical agents are also disclosed.

Abstract: The present invention relates to an auxiliary contact block. The auxiliary contact block has a housing and a tool free latching mechanism. The tool free latching mechanism has a stationary member integral to the housing and a latching bar.

Abstract: Osteoporosis is one of the major problems in our aging society. Osteoporosis results in bone fracture in older members of the population, especially in post-menopausal women. In traditional medicine, there are many natural crude drugs that have the potential for use to treat bone diseases. So far, there is no report in literature on anti-osteoporosis (bone forming) activity of Butea species. It was thought to study the anti-osteoporotic activity of this plant. Thus, the present invention provides a pharmaceutical composition from the extracts of Butea monosperma for prevention or treatment of bone disorders, process of preparation and use thereof.

Abstract: Novel mercaptophenyl naphthyl methane compounds, their pharmaceutically acceptable salts and compositions comprised thereof are useful for the prevention or treatment of various medical indications associated with estrogen dependent diseases or syndromes related to osteoporosis, bone loss, bone formation, cardiovascular disorders, neurodegenerative disorders, menopausal disorders, physiological disorders, diabetes disorders, prostatic carcinoma, cancer of breast, cancer of uterus, cancer of the cervix and cancer of the colon, threatened or habitual abortion, obesity, ovarian development or function, post-partum lactation and depression.